Treatment Strategy for Low-grade Gliomas

Status Terminated

Clinical Trial Summary

Although the prognosis of patients with low-grade glioma (LGG) is generally good, recurrence seems unavoidable in some patients because of the infiltrative growth of the tumors. How to treat LGGs is still under controversy. The role of radiation therapy and chemotherapy in the treatment of LGG need to be further investigated. The purpose of this study is the following:

1. to investigate the role of early radiation therapy in MRI-determined total resected LGGs;

2. to compare the efficacy of early radiation therapy and that of initial chemotherapy in the LGGs without total resection.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00897377
Study type	Interventional
Source	Sun Yat-sen University
Contact
Status	Terminated
Phase	Phase 3
Start date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02903784` - Neural Basis of Language Processing	N/A
Completed	`NCT00303849` - Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors	Phase 1/Phase 2
Completed	`NCT02530320` - Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved	Phase 2
Terminated	`NCT00389090` - A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma	Phase 2
Active, not recruiting	`NCT02209428` - A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas	Phase 2
Active, not recruiting	`NCT01089244` - FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma	N/A
Completed	`NCT00717210` - Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide	Phase 3
Completed	`NCT00089427` - IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma	Phase 1
Recruiting	`NCT04623931` - Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas	Phase 2
Terminated	`NCT01281982` - (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
Recruiting	`NCT01849952` - Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
Withdrawn	`NCT03353896` - NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma	N/A
Active, not recruiting	`NCT03180502` - Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma	Phase 2
Completed	`NCT00874861` - HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas	Phase 0